FDA e amohetse sesebelisoa sa pele sa tekanyetso ea insulin e ikemetseng bakeng sa Tšoaea 2 lefu la tsoekere boemo.
Sena se latela katoloso ea sesupo sa thekenoloji ea Insulet SmartAdjust (e leng "interoperable automated glycemic controller) e bonts'itsoeng taolo ea Mofuta oa lefu la tsoekere la 1. Hona joale, theknoloji ena ea "Automated insulin dosing" e tla bontšoa 'me e be teng bakeng sa taolo ea Tšoaea 2 lefu la tsoekere hammoho.
Tumello ena ea FDA e ipapisitse le liphuputso tsa teko ea bongaka mabapi le tšebeliso ea theknoloji ea Insulet SmartAdjust ke batho ba nang le Tšoaea 2 lefu la tsoekere ka kalafo ea insulin. Boithuto bo fumane hore theknoloji e bolokehile ebile e ntlafalitse taolo ea tsoekere ea mali ho barupeluoa.
Insulet SmartAdjust technology, e leng "interoperable automated glycemic controller" ke software e fetolang phano ea insulin ho motho ea nang le lefu la tsoekere ka ho hokela pompong e 'ngoe e nolofalitsoeng ea "insulin" (ACE pump) le "integrated continuous glucose monitor" (iCGM).
Tšoaea 2 lefu la tsoekere boemo ho batho ba bangata ha bo arabele hantle tsamaisong e seng ea bongaka le kalafo ka matlapa a anti-diabetic. Batho ba joalo ba hloka ho ipehela insulin hanngoe kapa ho feta ka letsatsi ba sebelisa ente kapa pene ea insulin kapa pompo ho boloka boemo ba tsoekere ea mali bo le boemong bo sireletsehileng. Sena se hloka ho hlahlojoa khafetsa maemo a tsoekere ea mali bakeng sa litholoana tse ntle. Sesebelisoa sa Insulin Dosing e tla ba khetho e bohlale ea batho ba joalo e ka ntlafatsang bophelo ba bona.
***
mehloling
- Phatlalatso ea litaba ea FDA - FDA e Hlakola Sesebelisoa sa Pele ho nolofalletsa Batho ba nang le lefu la tsoekere la Mofuta oa 2. E ngotsoe 26 August 2024. E fumaneha ho https://www.fda.gov/news-events/press-announcements/fda-clears-first-device-enable-automated-insulin-dosing-individuals-type-2-diabetes
***
